...
- Log into the Research Environment
- Open LabKey by double-clicking on the LabKey icon on the desktop
- Sign in using the same credentials you used to access the Research Environment by clicking 'sign-in' in the top-right of the browser window
- At this point no data will be visible and you will be taken to an empty LabKey page
- You now need to send an email to Genomics England Service Deskentitled 'GeCIP researcher <username> requesting LabKey access' stating in the email body that you have successfully logged into LabKey within the Research Environment and are not requesting that your account be upgraded and you are given access to the LabKey projects to which you are entitled.
- You will be notified when this has been completed, and the next time you log into LabKey you should have access to the appropriate data.
...
As you will know from the process you have gone through to get access ot to the research environmentResearch Environment, access is granted based on a set of rules:
...
It is through these requirements that we are able to maintain our commitment to patient anonymity and security, and to gain the highest possible value form from the 100,000 genome project Genomes Project dataset.
Patient consent model and de-identification
...
The conditions of access to the research environment include a commitment to not attempt to re-identify a patient by reverse engineering a health record.
It is also not a given assumed that a particular patient’s data will remain part of the dataset. They are entitled to withdraw their consent for their data to be used at any time.
...
To ensure a high standard of data security and integrity, access to the research environment is only granted when you, the researcher, has undergone mandatory information governance training. This involves attending completing an online training session followed by an online test. To access to the research environment, you must achieve a pass mark of at least 80%.
In support of this, researcher activity and behavior behaviour within the environment are monitored. This enables Genomics England to define and maintain the level of standards that will encourage more patients to want to be included in the project and to attract high-calibre researchers from around the world to want to participate.
...
Membership of a GeCIP domain and access to the research environment Research Environment is on the understanding that all outputs of the research and all intellectual property (IP) are automatically wholly owned by Genomics England. This is the case when that research is conducted entirely within the GeCIP programme and when not using assets owned by third parties. In other circumstances, where non-GeCIP assets are involved, IP ownership will be negotiable.
...
There is a separate document, Genomics England IP Policy ##needs link##, available from the Genomics England website, that you are encouraged to read as it includes sections on patents and the licensing of IP.
...
However, Genomics England has in place a nine-month moratorium on the publication of results to provide a degree of preferential permission to publish on participant data. This is in recognition of those domains and individuals that have assisted in recruiting to the project. In effect, the moratorium will prevent other GeCIP researchers from publishing research on that domain’s corresponding data until the domain has had access to the data for at least nine months. The nine-month trigger point is when a meaningful number of whole genomes are available to researchers in a specific domain has been reached. More detail on the Genomics England publication moratorium policy can be found in the Publication Moratorium ##needs link## policy document available at on our website.
Given that the research will be based on work carried out in theGenomics England research environmentthe Genomics England Research Environment, and within a GeCIP domain, all publications will be made ‘on behalf of the 100,000 Genomes Project and Genomics England’ as a banner heading. In general, issues relating to authorship (whom to include, the order of, etc) will follow the guidelines issued by the International Committee of Medical Journal Editors (ICMJE). For a full description of how and when to publish your results, please refer to the Genomics England Publication Policy ##needs link## available at our website. It includes detailed sections on authorship, patentability and review.
...
- Link to Participation Agreement when updated
- Link to IP Policy when updated
- Get details of the encrypted password thing and password safety tip[s
- add in changing password - is this possible?
- Exact steps in IG training course
- Publication Moratorium & Publication Policy link